Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating activities:
Net income	$ 9,508	$ 7,730
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,126	2,148
Amortization of right of use lease assets	408	430
Accretion related to acquisition, net	44	44
Amortization of subordinated debt issuance costs	131	130
Provision for credit losses	713	2,601
Loss on sale of securities, net	0	134
Net amortization of securities	519	710
Decrease (increase) in loans held for sale, net	470	(49)
Net gain on disposal of premises and equipment	0	(220)
Net loss on write-down/sale of repossessed assets	126	69
Income from bank owned life insurance	(1,094)	(1,038)
Stock compensation expense	462	546
Deferred tax benefit	(145)	(88)
Increase (decrease) in other assets	1,109	(1,093)
Increase (decrease) in accrued expenses and other liabilities	267	(1,058)
Net cash provided by operating activities	14,644	10,996
Investing activities:
Purchases of available-for-sale securities	(34,648)	(11,734)
Proceeds from redemption (purchases) of restricted securities, net	1,258	(681)
Proceeds from maturities and calls of available-for-sale securities	1,570	890
Proceeds from sales of available-for-sale securities	0	19,821
Paydowns on available-for-sale securities	17,211	14,687
Net (increase) decrease in loans held for investment	66,684	(55,109)
Purchases of premises and equipment	(1,411)	(1,053)
Proceeds from sale of premises and equipment	0	863
Net cash provided by (used in) investing activities	50,664	(32,316)
Financing activities:
Increase (decrease) in noninterest-bearing deposits	23,049	(86,590)
Increase in savings deposits	3,751	71,167
(Decrease) increase in time deposits	(2,283)	89,801
Increase (decrease) in federal funds purchased, repurchase agreements and other borrowings, net	1,584	(13,982)
Increase in Federal Home Loan Bank advances	104,336	457,300
Repayment of Federal Home Loan Bank advances	(133,786)	(433,950)
Proceeds from Employee Stock Purchase Plan issuance	117	131
Cash dividends paid on common stock	(2,838)	(2,817)
Net cash (used in) provided by financing activities	(6,070)	81,060
Net increase in cash and cash equivalents	59,238	59,740
Cash and cash equivalents at beginning of period	80,806	21,066
Cash and cash equivalents at end of period	140,044	80,806
Cash payments for:
Interest	23,945	17,159
Income tax	1,050	2,100
Supplemental schedule of noncash transactions
Unrealized gain on securities available-for-sale	504	4,098
Loans transferred to repossessed assets	1,883	215
Impact of adoption of new accounting pronouncements	$ 455	$ 991